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Short Communication
Human µ-Calpain: Simple Isolation from Erythrocytes
and Characterization of Autolysis Fragments
sist of homologous large, catalytic subunits (80 kDa) and
identical small, regulatory subunits (30 kDa) (see Johnson
and Guttmann, 1997; Sorimachi et al., 1997; Carafoli and
Molinari, 1998; Ono et al. 1999, and for a review Wang
et al., 1999). The cDNAs of several isoforms are known
(Emori et al., 1986; Sorimachi et al., 1993; Graham-
Siegenthaler et al., 1994; Sorimachi et al., 1996; Dear
et al., 1997). Calpains have pathophysiological roles in
human disorders such as muscle dystrophy, traumatic
brain injury, spinal cord injury, cerebral ischemia, myocar-
dial infarction and cataract formation. However, their
physiological functions are not yet well understood, and
the literature presents a lot of conflicting data on activa-
tion, autolysis and protein interactions of calpains (for re-
views see Wang and Yuen, 1994; Krampfl et al., 1997;
Carafoli and Molinari, 1998; Wang and Yuen, 1999). The
calcium-activated proteases were first described in the
sixties (Guroff, 1964), purified in the eighties (Yoshimura
et al., 1983; Kitahara et al., 1984; Zimmermann and
Schlaepfer, 1984; Crawford et al., 1987) and isolated by
improved affinity chromatography in the nineties (Moli-
nari et al., 1995; Anagli et al., 1996). But even today isola-
tion of µ-calpain is a difficult task (Croall, 2000; Thomp-
son and Goll, 2000). Frequently, SDS polyacrylamide gel
electrophoresis reveals more bands than the expected
80 kDa and 30 kDa forms. Here, we describe an opti-
mized isolation procedure for µ-calpain from human ery-
throcytes which yields a pure, highly active and relatively
stable enzyme.
Purification of human µ-calpain was performed at 4 °C.
Erythrocyte concentrate (600 ml corresponding to 1 liter
of whole blood) was washed twice with washing solution
(0.15 M NaCl, 2 mM EDTA, pH 7.5) and centrifuged
(1000 g), lysed for 15 min at room temperature with lysing
buffer (15 mM Tris-HCl, 2 mM EDTA, pH 7.5, 0.5 mM Pefa-
bloc) and centrifuged again (1 h, 20 000 g). The super-
natant was diluted 1:1 (v/v) with buffer A (20 mM Tris/HCl,
2 mM EDTA, pH 7.5) and applied to an equilibrated DEAE-
Sepharose column (Pharmacia XK 50/30). The column
was washed with buffer A until E280 <0.010 and equilibrat-
ed with a mixture of 87:13 parts (v/v) of buffer A and
buffer B (20 mM Tris/HCl, 2 mM EDTA, pH 7.5, 0.5 M NaCl).
Calpain/calpastatin complexes were eluted with buffer B,
adjusted to 1.2 M NaCl and applied to a Phenyl-
Sepharose column (Pharmacia XK 50/20) equilibrated
with 1.2 M NaCl in buffer C (20 mM Tris/HCl, 2 mM EDTA,
pH 7.3). Elution of µ-calpain was performed by a de-
scending linear gradient from 1.2 to 0 M NaCl in buffer C.
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Heterodimeric µ-calpain, consisting of the large (80
kDa) and the small (30 kDa) subunit, was isolated and
purified from human erythrocytes by a highly repro-
ducible four-step purification procedure. Obtained
material is more than 95% pure and has a specific ac-
tivity of 6 – 7 mU/mg. Presence of contaminating pro-
teins could not be detected by HPLC and sequence
analysis. During storage at – 80 °C the enzyme re-
mains fully activatable by Ca2+, although the small
subunit is partially processed to a 22 kDa fragment.
This novel autolysis product of the small subunit
starts with the sequence 60RILG and is further
processed to the known 18 kDa fragment. Active
forms and typical transient and stable autolysis prod-
ucts of the large subunit were identified by protein se-
quencing. In casein-zymograms only the activatable
forms 80 kDa+30 kDa, 80 kDa+22 kDa and 80 kDa+18
kDa displayed caseinolysis.
Key words: Autolysis /Calcium activation /Calpain /
Cysteine proteases /Purification.
Calpains are intracellular calcium-dependent cysteine
proteinases with enzymatic activity at neutral pH. Two
ubiquitous types are well characterized, µ- und m-Cal-
pain (Calpain I and II). These multidomain proteins con-
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Active fractions were collected (positive in the casein-
Coomassie test; Buroker-Kilgore and Wang, 1993), con-
centrated by ultrafiltration to 10 ml (Amicon 10 kDa cut-
off membrane) and further purified on Superdex 200
(Pharmacia 100/3) equilibrated with 0.4 M NaCl in buffer
C. The eluted active fractions were applied to a Blue-
Sepharose column (Pharmacia Blue Sepharose Hi Trap 5
ml prepacked), washed with 0.25 M NaCl in buffer C and
eluted by a stepwise gradient from 0.25 to 0 M NaCl in
buffer C. Finally, isolated µ-calpain was concentrated
and stored in aliquots (1 – 2 mg/ml).
We routinely obtained approx. 1.5 to 2 mg of highly pu-
rified µ-calpain from 600 ml of human erythrocyte con-
centrate. The isolation procedure includes 4 main steps:
ion exchange chromatography, hydrophobic interaction
chromatography, gel filtration and affinity chromatogra-
phy in a very reproducible manner. In fresh preparations
two single protein bands were obtained after SDS-PAGE
(Laemmli, 1970) corresponding to apparent molecular
masses of 80 kDa and 30 kDa (Figure 1). These two
bands were primarily identified by anti-domain II and
anti-30 kDA monoclonal antibodies as the large and
small subunit of µ-calpain (data not shown). Direct Ed-
man degradation of eluted bands failed because the N-
termini of both subunits are blocked, but endoproteinase
Lys-C cleavage, peptide mapping and partial peptide se-
quencing of two selected peptides yielded internal se-
quences of the corresponding subunits.
Fresh material was analyzed by reversed-phase HPLC
(Figure 2). Three fractions were separated: the latest elut-
ing fraction C consists of pure heterodimeric µ-calpain
(80 kDA und 30 kDA); its composition was determined by
endoproteinase Lys-C cleavage, peptide mapping and
protein sequencing (21Q-R-A-R-E-L-G- for the 80 kDa-
form and 126V-V-T-R-H- for the 30 kDa-form). Fraction B
(about 20% by weight of total) consists of pure homoge-
neous 30 kDa subunit (164R-W-Q-A-I-Y-). The small frac-
tion A (about 20% by weight of total) is a mixture of three
heterogenously cleaved 30 kDa-forms, (-M-R-I-)↓62L-G-
G-V-I-S-, (-G-V-I-)↓68S-A-I-S-E-A-A- and (-S-A-I-)↓71S-
E-A-A-A-Q-. These three minor fractions represent ‘au-
tolysed’ fragments that have not been described so far.
Unexpectedly, the purified calpain shows a new promi-
nent band at 22 kDA in SDS-PAGE after short storage at
4 °C and after longer storage at – 80 °C (Figure 3), al-
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Fig. 1 SDS-PAGE Documenting the Purification of µ-Calpain.
Lane 1, µ-calpain fraction obtained after phenyl-Sepharose; lane
2, µ-calpain fraction after gel filtration; lane 3, material not re-
tained by the Blue-Sepharose column; lane 4, purified µ-calpain
obtained after Blue-Sepharose chromatography.
Fig. 2 Separation of Freshly Purified µ-Calpain by HPLC.
Purified calpain (20 µg) was analyzed by reversed-phase HPLC
with Aquapore RP 300 (Applied Biosystems GmbH, Weiterstadt,
Germany) and a linear gradient of 0 – 80% (v/v) acetonitrile in
0.1% (v/v) trifluoroacetic acid and 30% (v/v) isopropanol at a
flow rate of 1 ml/min. Absorption was recorded at 206 nm. Sam-
ples were analyzed by SDS-PAGE and sequenced after transfer
to PVDF membranes using a gas-phase sequenator 473A (Ap-
plied Biosystems GmbH) according the instructions of the man-
ufacturer.
Fig. 3 In vitro Autolysis of Human µ-Calpain Followed by SDS-
PAGE.
Lane 1, purified µ-calpain after storage for 2 weeks at – 80 °C;
lanes 2 – 8, autolytic fragments 0 min (2), 1 min (3), 5 min (4), 15
min (5), 30 min (6), 60 min (7) and 120 min (8) after addition of 0.5
mM free Ca2+ (final concentration) to purified µ-calpain (27.5 µg)
in 50 mM Tris-HCl, pH 7.5, 100 mM NaCl and 1 mM DTT at room
temperature. After the indicated time intervals aliquots were tak-
en (1.1 µg), EDTA was added (25 mM final concentration) and the
material was applied to the gel.
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though the material was kept in 2 mM EDTA. The N-termi-
nal sequence of the 22 kDa fragment, 60R-I-L-E-, is locat-
ed in domain V 26 or 32 amino acids upstream of the
well-known 21 kDa (86H-Y-S-N-I-E-) or 18 kDa (92A-N-E-
S-E-) autolysis products of the 30 kDa form (Emori et al.,
1986; McClelland et al., 1989; Nishimura and Goll, 1991;
Figure 4). The cleavage leading to this novel fragment
may be due to (i) an undetected contaminating protease,
or (ii) to a minor ‘dormant’ activity of purified µ-calpain it-
self. It can be hypothesized further that the cleavage site
may be located close to the broad active-site cleft of cal-
pain (Hosfield et al., 1999; Strobl et al., 2000). A compa-
rable 23 kDa autolysis product of the small subunit 
(64G-V-I-S-A-, starting 4 amino acid residues upstream of
60R-I-L-G-A-Q-) was described by McClelland and
coworkers after Ca2+-activation (McClelland et al., 1989).
Heterogeneity of EDTA-stored µ-calpain, due to the for-
mation of the 22 kDa fragment, may explain the fact that
extended crystallization experiments with our purified
enzyme were not successful (W. Bode, personal commu-
nication). Figure 4 summarizes the complex pattern of
transient (80 kDa, 78 kDa, 76 kDa, 55 kDa, 30 kDa, 21
kDa) and stable (40 kDa, 28 kDa, 24 kDa, 18 kDa) autoly-
sis products of our purified µ-calpain.
Enzymatic activity of µ-calpain was measured in ‘con-
tinuous’ fluorimetric assays using Suc-Leu-Tyr-NH-Mec
(250 µM) as substrate at 12 °C, pH 7.5, with 200 µM CaCl2
as described in detail previously (Garcia-Diaz et al.,
2001). The purified enzyme had a specific activity be-
tween 5 and 7 mU/mg under the conditions given above.
After extrapolation to saturating substrate concentra-
tions, this value (123 mU/mg) corresponds well to the
specific activity of porcine calpain (76.3 mU/mg) reported
by Sasaki et al. (1984).
Fresh and stored purified calpains were analyzed by
casein zymography before and after activation using
non-denaturing gel electrophoresis (Raser et al., 1995).
As little as 10 ng fresh µ-calpain (80 kDa and 30 kDa) was
detected as a single band. If 5 µg were applied, two addi-
tional quicker migrating tiny bands could be detected
(Figure 5; line µ#). With stored µ-calpain we found two
strong caseinolytic activities which represent the 80
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Fig. 4 Scheme of Observed Autolysis Fragments of Purified µ-Calpain after Calcium Activation.
Cleavage points are identified by their N-terminal sequences.
Fig. 5 Comparison of Purified µ-Calpain from Human Erythro-
cytes in SDS-PAGE, Native PAGE and PAGE Containing Casein
(Casein-PAGE).
µ, purified µ-calpain (1 µg) immediately after isolation; µ*, puri-
fied µ-calpain (1 µg) after storage for 2 weeks at – 80 °C; µ#, pu-
rified µ-calpain (5 µg) immediately after isolation.
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kDa+30 kDa and 80 kDa+21 kDa forms (Figure 5; line µ*).
No caseinolytic activity was found when already activat-
ed µ-calpain forms (78 kDa+18 kDa, 76 kDa+, 18 kDa)
were applied to the zymograms (data not shown). This
may be explained by further autolysis of the activated
forms during electrophoresis leading to inactivation. All
caseinolytic bands were completely inhibited by the re-
combinant calpastatin domain I and by the inhibitor Z-
LLY-CHN2.
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